Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications

Moysan, Elodie, Bastiat, Guillaume, Benoit, Jean-Pierre·2013·Molecular Pharmaceutics

DOI 10.1021/mp300370t

Cited by (232)

Items 201–232 of 232

In vivo Assessment of the Hepatotoxicity of Mixed Gemcitabine and 5-Fluorouracil Loaded on Microemulsion in Mice Bearing Ehrlich Ascites Carcinoma
Mayson H. Alkhatib, May M. Alasmari, Faiza Abdo · 2017 · Advances in Pharmacology and Pharmacy
Tumor Microenvironment and Intracellular Signal-Activated Nanocomposites for Anticancer Drug Delivery
Yilan Huang, Yiheng Huang, Yuefei Zhu, Xiaowen Zhu, Zhiqing Pang · 2021 · Materials horizons
Efficacy and Mechanism of Action of a Novel Class of Antic-Cancer Drugs
Teran, Claudia · 2016 · uO Research (University of Ottawa)
Organofluorine-containing anticancer therapeutics
Magdalena Ślusarczyk · 2015
PERBANDINGAN INHIBISI BRUSEIN D TERHADAP PROTEIN NFKB PADA SEL KANKER PANKREAS SECARA FLEKSIBEL DAN RIGID DOCKING
Sekolah Tinggi Teknologi Industri dan Farmasi Bogor, Harry Noviardi, Armi Wulanawati, Institut Pertanian Bogor, Muhammad Sholehuddin malik Ibrohim · 2017 · Jurnal Farmamedika (Pharmamedica Journal)
Self-assembling Phosphoramidate Pronucleotides: Enzymatic Regulation and Application Towards Therapeutic Delivery
Harrison T. West · 2019 · University of Minnesota Digital Conservancy (University of Minnesota)
Research Progress in Drug Resistance and Structural Modification of Gemcitabine
悦万 · 2023 · Pharmacy Information
Targeting Intracranial Tumours with a Combination of RNA and Chemotherapy
Abdulhamid S. Fatani, Andreas G. Schätzlein, Ijeoma Florence Uchegbu · 2024 · Pharmaceutics
Computational photochemistry: advances in 2022–2023
Miriam Navarrete‐Miguel, Juliana Cuéllar-Zuquin, Javier Carmona‐García, Abdelazim M. A. Abdelgawwad, Iván Soriano-Díaz, Juan Carlos Roldao, Debabrata Halder, Ana Borrego‐Sánchez, Antonio Francés‐Monerris, Angelo Giussani et al. · 2024 · Royal Society of Chemistry eBooks
Carboxymethyl-β-1,3-D-glucan (CMG)-gemcitabine conjugate improves the anticancer efficacy and alleviate the toxicity of gemcitabine (GEM)
Maxin Ji, Yudong Zhang, Yilong Duan, Yuqing Zhao, Guangyue Su · 2025 · Natural Product Research
Breast Cancer: Epidemiology, Symptoms, Risk Factors, Pathogenesis, Classification, Current Treatments and Various Approaches in Nano-formulations
Nitish Kumar, Balram Balram, Gurvirender Singh, Dushyant, Smita Narwal, Ashwani K. Dhingra · 2025 · Current Cancer Therapy Reviews
Some stereoisomers and tautomers of gemcitabine – A DFT treatment
Lemi Türker · 2025 · Earthline Journal of Chemical Sciences
Challenges in traditional TNBC therapies
Somdatta Y. Chaudhari, Aishwarya Pandit, Mukund Salunke, Shailaja Jadhav, Aarti Kulkarni, Sachin Namdeo Kothawade · 2025 · Elsevier eBooks
Additional file 2 of Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer
Andriana Inkoom, Ndemazie, Nkafu Bechem, Taylor Smith, Esther Frimpong, Raviteja Bulusu, Rosemary A. Poku, Zhu, Xue, Han, Bo, Trevino, Jose, Edward Agyare · 2024 · Figshare
Additional file 1 of Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer
Andriana Inkoom, Ndemazie, Nkafu Bechem, Taylor Smith, Esther Frimpong, Raviteja Bulusu, Rosemary A. Poku, Zhu, Xue, Bo Han, Trevino, Jose, Edward Agyare · 2024 · Figshare
Nouveau concept de resensibilisation à la chimiothérapie en activant la nucléoside kinase dCK par le masitinib, un inhibiteur de protéines tyrosine kinases
Kahina Hammam · 2014
Photocaging the C6-carboxylate of β-glucuronide prodrugs enables spatiotemporally controlled release of anticancer agents via a dual activation strategy
Junjie Fu, Dianya Yong, Jie Liu, Yunying Tan, Hongyu Yang, Jing Hu, Jian Yin · 2026 · Organic & Biomolecular Chemistry
Contribution à l'étude des mécanismes moléculaires de chimiorésistance des cellules cancéreuses pancréatiques
Marion Gayral · 2015 · theses.fr (ABES)
Hydrogel de nanocapsules lipidiques combinées au peptide de ciblage NFL-TBS.40-63 pour la prévention de récurrences de glioblastome
Claire Gazaille · 2020
Self-Assembly Regulation, Drug Release Behavior, Anti-Multidrug Resistance of Redox-Responsive Gemcitabine–Quinine Nanoassemblies in Glioblastoma Therapy
Jiayi Zuo, Shuhui Qu, Haoping Long, Ting Yuan, Jinqiu Liang, Feng Jiang · 2026 · Langmuir
Dual Metabolic Blockade in Pancreatic Cancer: Potent Anticancer Activity of Mitochondria-Targeted Glycolysis and OXPHOS Inhibitors
闫海波, Dongsheng Li, Min Yang, Mingyang Xu, Ying Yang, Zhenzhen Dai, Jiamin Ou, Yingjie He, Biao Xu, Shaolin Zhang · 2026 · Journal of Medicinal Chemistry
Poly-β-Cyclodextrin as a Superior Host for Gemcitabine: Comparative Supramolecular Characterization and Anticancer Evaluation
Manickam Sathya, Archana Sumohan Pillai, Varnitha Manikantan, Sengodan Amudha, Ujma Ashapak Tamboli, Ramaraj Rajesh Kumar, Aleyamma Alexander, Israel V.M.V. Enoch · 2026 · Journal of Solution Chemistry
Magadiite-based delivery system with sustained release of gemcitabine and its cytotoxicity against HepG2 cells
Xuling Weng, Fang Guo, Yu Zhong, Wanyun Feng, Xiaoqiang Shang, Yufeng Chen · 2026 · Chemical Papers
A Dual-Action CXCR4-Targeted Peptide−Drug Conjugate Engineered to Enhance Antitumor Efficacy and Mitigate Myelosuppression in Pancreatic Cancer
Ke Zhu, Xuanxin Liu, Dapeng Li, Tao Wang, Tao Wen, Xiaocui Fang, Yanlian Yang, Jian Liu, Jie Meng, Chen Wang et al. · 2026 · Molecular Pharmaceutics
HMHLVI: Hybrid Multi-view Hypergraph Learning with Variational Inference for snoRNA-Drug Association Prediction
Tiyao Liu, Shudong Wang, Dapeng Wang, Shaoqiang Wang, Shanchen Pang · 2026 · Interdisciplinary Sciences Computational Life Sciences
A novel nanoparticle-based co-delivery system of Fritillaria persica L . extract and gemcitabine for inhibiting breast cancer progression
Reyhaneh Arefimehr, Mehrad Zibaei Moghadam, Negar Jamshidi, Nazanin Jamshidi · 2026 · Beilstein Journal of Nanotechnology
BindingDB Entry 50013685: Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable "click" oxime bond tethers and preclinical evaluation against prostate cancer.
BindingDB · 2022 · UC San Diego
BindingDB Entry 50044081: N-Acyl-phosphoramidates as potential novel form of gemcitabine prodrugs.
BindingDB · 2015 · UC San Diego
BindingDB Entry 50012568: Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity.
BindingDB · 2022 · UC San Diego
BindingDB Entry 50015330: Integrin-Mediated Targeted Cancer Therapy Using c(RGDyK)-Based Conjugates of Gemcitabine.
BindingDB · 2023 · UC San Diego
BindingDB Entry 50016140: Design, synthesis and antitumor activity study of a gemcitabine prodrug conjugated with a HDAC6 inhibitor.
BindingDB · 2023 · UC San Diego
BindingDB Entry 50011989: Development of potent CPP6-gemcitabine conjugates against human prostate cancer cell line (PC-3).
BindingDB · 2022 · UC San Diego